Investing.com -- Alto Neuroscience Inc (NYSE:ANRO) stock surged 81% Monday after the company announced a successful FDA meeting that will accelerate development of its treatment-resistant depression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback